115 filings
Page 2 of 6
8-K
o1qfs 9653d
3 Aug 23
Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
8-K
0hn1or1if tiim28
21 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
pz8ls3nydg9at5uyjz01
1 Jun 23
Regulation FD Disclosure
4:25pm
424B5
mkkw 3wnc
19 May 23
Prospectus supplement for primary offering
4:09pm
8-K
6o6lupe3ryqeaar1twiy
19 May 23
Prelude Therapeutics Announces Launch of Proposed Public Offering
4:06pm
FWP
6eonddk4 xor70t
18 May 23
Free writing prospectus
6:05am
424B5
1kuuj8tdu5975 9q9d
17 May 23
Prospectus supplement for primary offering
4:26pm
8-K
hjqoll2y
17 May 23
Other Events
4:03pm
8-K
g0bajf gz
8 May 23
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
8:06am
ARS
76iha
28 Apr 23
Annual report to shareholders
9:46am
DEFA14A
rn0hs96aqd6k
28 Apr 23
Additional proxy soliciting materials
9:41am
PRE 14A
ltqpcty5
18 Apr 23
Preliminary proxy
4:00pm
8-K
19kxddun
15 Mar 23
Entry into a Material Definitive Agreement
4:38pm
424B5
r24vyh
15 Mar 23
Prospectus supplement for primary offering
4:33pm
S-8
a2d1eop9hf4 89zn
15 Mar 23
Registration of securities for employees
9:17am
8-K
5kqjbt
15 Mar 23
Prelude Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
8:31am
8-K
f5ie3jxwg2db
14 Feb 23
Regulation FD Disclosure
11:14am